Resources>Blog>AI and Computational Approaches in Antibody Research

AI and Computational Approaches in Antibody Research

Biointron 2024-01-24 Read time: 1 min
AI.jpg
Image credit: DOI: 10.3390/ijerph18010271

Artificial intelligence (AI) and computational methods are a powerful tool for antibody discovery and antibody optimization. Despite historical prevalence in small molecule-related applications, AI is progressively being utilized in the discovery and advancement of therapeutic antibodies, backed by the surge in computational power and innovative algorithms, with an increasing amount of data obtained through next-generation sequencing and related drug modalities such as VHH antibodies.1

The main uses of these approaches in antibody research involve2: 

These computational methods can provide much more cost-efficient and rapid turnaround time compared to the laborious experimental methods that are common in antibody discovery. Escalating costs are often a significant impediment to the advancement of drug discovery.


At Biointron, we are dedicated to accelerating your antibody discovery, optimization, and production needs. Our team of experts can provide customized solutions that meet your specific research needs. Contact us to learn more about our services and how we can help accelerate your research and drug development projects.


References:

  1. Norman, R. A., Ambrosetti, F., Bonvin, A. M., Colwell, L. J., Kelm, S., Kumar, S., & Krawczyk, K. (2020). Computational approaches to therapeutic antibody design: Established methods and emerging trends. Briefings in Bioinformatics, 21(5), 1549-1567. https://academic.oup.com/bib/article/21/5/1549/5581643

  2. Kim, J., McFee, M., Fang, Q., Abdin, O., & Kim, P. M. (2023). Computational and artificial intelligence-based methods for antibody development. Trends in Pharmacological Sciences, 44(3), 175–189. https://www.cell.com/trends/pharmacological-sciences/fulltext/S0165-6147(22)00279-6


Recommended Articles
Antibodies After Hours: From Algorithms to Antibodies – South San Francisco

Biointron’s Antibodies After Hours: From Algorithms to Antibodies was held at Th……

Sep 16, 2026
The Wet-Lab Validation Engine Behind AI-Driven Antibody Discovery

Discover how high-throughput wet-lab validation connects AI-designed antibody se……

Sep 11, 2026
Hybridoma Generation in the Monoclonal Antibody Production Process

Understand the hybridoma generation process for monoclonal antibody production, ……

Sep 08, 2026
AI Antibody Discovery: From Computational Design to Experimental Validation

Artificial intelligence (AI) is changing how therapeutic antibodies are discover……

Sep 04, 2026

Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.